| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |